The Department of Neurology at the University of Michigan is seeking applicants for a postdoctoral opportunity to work with Dr. Maria do Carmo Costa and Dr. Henry Paulson on translational mechanistic studies for the neurodegenerative disease Spinocerebellar Ataxia type 3 (SCA3).
SCA3 is a fatal polyglutamine disease with no cure. Our ultimate goal is to develop an effective therapy for SCA3 patients.
We welcome applications from candidates with expertise in neuroscience and molecular and cellular biology. This is an interdisciplinary project with plenty of opportunities to learn new skills in biochemistry, molecular and cellular biology, high-throughput small-molecule and genetic screens, stem cells, and mouse models of disease.
- Design and carry out experiments independently
- Analyze and interpret data
- Organize and present data
- Write manuscripts for publication
M.D. or Ph.D. in related field.
Excellent communication skills (written and oral)
Michigan Medicine conducts background screening and pre-employment drug testing on job candidates upon acceptance of a contingent job offer and may use a third party administrator to conduct background screenings. Background screenings are performed in compliance with the Fair Credit Report Act.
Michigan Medicine improves the health of patients, populations and communities through excellence in education, patient care, community service, research and technology development, and through leadership activities in Michigan, nationally and internationally. Our mission is guided by our Strategic Principles and has three critical components; patient care, education and research that together enhance our contribution to society.
Job openings are posted for a minimum of seven calendar days. This job may be removed from posting boards and filled anytime after the minimum posting period has ended.
U-M EEO/AA Statement
The University of Michigan is an equal opportunity/affirmative action employer.